Tatva Chintan Pharma Chem Ltd

Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (SEBI Listing Regulations) we enclose herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30 June 2023.The said Results were reviewed and recommended by Audit Committee and approved by the Board of Directors of the Company in their respective meetings held on 04 August 2023.Further we enclose herewith Limited Review Report issued by M/s. NDJ & Co. Chartered Accountants (Firm Registration No. 136345W) Statutory Auditors of the Company as required under Regulation 33 of SEBI Listing Regulations.The above information shall be made available on the website of the Company at www.tatvachintan.com.The Board meeting commenced at 11:30 A.M. and concluded at 02:45 P.M.